Benzinga | May 5, 2021 04:54PM EDT

bluebird bio Q1 EPS $(3.07) Up From $(3.64) YoY, Sales $12.79M Down From $21.86M YoY

bluebird bio (NASDAQ:BLUE) reported quarterly losses of $(3.07) per share. This is a 15.66 percent increase over losses of $(3.64) per share from the same period last year. The company reported $12.79 million in sales this quarter. This is a 41.48 percent decrease over sales of $21.86 million the same period last year.